After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Drug Manufacturers – Specialty & Generic industry segment, falling under the Healthcare sector. The current market capitalization of Supernus Pharmaceuticals Inc is $2.75B. A total of 1.05 million shares were traded on the day, compared to an average of 823.99K shares.
In the most recent transaction, Khattar Jack A. sold 59,900 shares of SUPN for 50.57 per share on Oct 09 ’25. After the transaction, the President, CEO now owns 1,206,578 company shares. In a previous transaction on Oct 09 ’25, NEWHALL CHARLES W III sold 25,000 shares at 50.77 per share. SUPN shares that Director owns now total 104,644.
Among the insiders who bought shares, JACK A. KHATTAR acquired of 59,900 shares on Oct 09 ’25 at a per-share price of $48.00. In another insider transaction, CHARLES NEWHALL bought 25,000 shares at $48.00 per share on Oct 09 ’25.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, SUPN has a high of $51.78 and a low of $29.16.
As of this writing, SUPN has an earnings estimate of $0.26 per share for the current quarter. EPS was calculated based on a consensus of 1.0 estimates, with a high estimate of $0.26 per share and a lower estimate of $0.26. The company reported an EPS of $1.1 in the last quarter
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. SUPN’s latest balance sheet shows that the firm has $339.68M in Cash & Short Term Investments as of fiscal 2021. There were $427.03M in debt and $315.38M in liabilities at the time. Its Book Value Per Share was $18.96, while its Total Shareholder’s Equity was $815.85M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock.
